Caladrius Biosciences (CLBS) PT Raised to $10 at Brookline Capital Markets

March 3, 2021 11:58 AM EST
Get Alerts CLBS Hot Sheet
Price: $1.53 -1.29%

Rating Summary:
    4 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Brookline Capital Markets analyst Kumaraguru Raja raised the price target on Caladrius Biosciences (NASDAQ: CLBS) to $10.00 (from $7.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change